Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
6
|
| pubmed:dateCreated |
1992-2-18
|
| pubmed:abstractText |
The prevalence of antibodies against the hepatitis C virus (anti-HCV) in patients seropositive for rheumatoid arthritis (RA) and suffering from this disease has been analyzed in comparison to a control group. Our results suggest that the high rate of prevalence found in RA patients is due to IgG interference in the measuring method used.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0392-856X
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
9
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
617-9
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading | |
| pubmed:articleTitle |
Rheumatoid arthritis and hepatitis C virus antibodies.
|
| pubmed:affiliation |
Laboratorio de Bioquímica, Hospital San Millán, Logrono, Spain.
|
| pubmed:publicationType |
Journal Article
|